Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “MASTITIS”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 523 records · Page 29Linked to original sources
PubMed1997

Treatment of bovine mastitis with houttuynin sodium bisulphate.

Houttuynin sodium bisulphate (HSB), alpha hydroxyl-capryl-ethyl-sodium-sulphonate, is a product formed by reacting sodium bisulphate with houttuynin, which is obtained from a medicinal herb Houttuynia cordata Thunb. From HBS an aqueous intramammary solution was made for the treatment of bovine clinical mastitis. A total of 104 acute and subacute mastitis cases were randomly assigned into two groups with 52 cases in each group: 1. an HSB group in which 80 mg HSB was infused into an affected gland; and 2. a PS group in which intramammary administration of 800,000 i.u. penicillin G in combination with 1 g of streptomycin (PS) was conducted. The treatments were administered twice daily until the inflammatory signs were eliminated and mammary secretion became normal. In acute mastitis, 88.2% (15 of 17) were clinically cured and 52.9% (nine of 17) microbiologically cured by HSB; in the PS group, 90.0% (18 of 20) were clinically cured and 55.0% (11 of 20) microbiologically cured. In subacute cases, the clinical and microbiological cure rates were 94.3% (33 of 35) and 45.7% (16 of 35) respectively, in the HSB group; and in the PS group the clinical and microbiological cure rates were 93.7% (30 of 32) and 43.8% (14 of 32), respectively. No statistically significant difference was found between HSB and PS groups in the treatment of acute as well as subacute mastitis. In addition, an inhibitory effect was found on the growth of lactic streptococcus in the milk collected within 48 h of intramammary treatment with penicillin G in combination with streptomycin. However, for HSB, a mild inhibitory effect on lactic streptococci was detected in the milk within 12 h of treatment.

Acute Disease↗
PubMed1981

Uncommon forms of mastitis.

Three different types of chronic mastitis were seen in a review of cases over a twenty-five-year-period. These were tuberculous mastitis, non-specific granulomatous mastitis, and oleogranulomatous mastitis. Their common modes of presentation and some of the difficulties encountered in diagnosing these lesions are discussed.

Acute Disease↗
PubMed2006

Therapeutic Chlamydophila abortus and C. pecorum vaccination transiently reduces bovine mastitis associated with Chlamydophila infection.

Infections with Chlamydophila abortus and C. pecorum are highly prevalent in cattle and have been associated with bovine mastitis. A prospective cohort study was conducted with a herd of 140 Holstein dairy cows to investigate the influence of Chlamydophila infection on subclinical inflammation of the bovine mammary gland as characterized by somatic cell numbers in milk. PCR detection of C. abortus and low serum antibody levels against Chlamydophila spp. were significantly associated with subclinical mastitis. To examine the effect of the infection by response modification, immune perturbation was done by two subcutaneous administrations of an experimental vaccine preparation of inactivated C. abortus and C. pecorum elementary bodies. Vaccination against Chlamydophila highly significantly decreased milk somatic cell numbers, thus reducing bovine mastitis, and increased antibody levels against Chlamydophila but did not eliminate shedding of C. abortus in milk as detected by PCR. The protective effect peaked at 11 weeks after vaccination and lasted for a total of 14 weeks. Vaccination with the Chlamydophila vaccine, a mock vaccine, or a combination vaccine against bovine viral diseases highly significantly increased C. abortus shedding in milk for 1 week, presumably mediated by the vaccine adjuvant. In summary, this study shows an etiological involvement of the widespread Chlamydophila infections in bovine mastitis, a herd disease of critical importance for the dairy industry. Furthermore, this investigation shows the potential for temporary improvement of chlamydial disease by therapeutic vaccination. Chlamydophila vaccination of cattle might serve as a testing ground for vaccines against human chlamydial infections.

Animals↗
PubMed1987

Isolation of Staphylococcus aureus L forms from experimentally induced bovine mastitis.

Bacterial L forms were isolated from milk samples of dairy cattle infected experimentally with Staphylococcus aureus. Initially, bacterial L forms were induced in vitro from 12 of 44 S. aureus strains isolated from bovine mastitis. Cows were experimentally infected in two experiments with strains shown in vitro to be easily inducible to L form and with S. aureus Newbould 305. Each quarter of the mammary gland was infected with either 10(3) or 10(6) CFU of the test strains. Treatment was initiated with 100,000 U of penicillin G per quarter at the first signs of clinical mastitis. Milk samples were collected daily and cultured on bovine blood agar and PPLO agar (Difco Laboratories, Detroit, Mich.) with 10% horse serum and 5% NaCl. Staphylococcal L forms were isolated from milk samples collected from infected glands in both experiments after antibiotic therapy. Glands with the highest concentrations of leukocytes and bacteria were most likely to yield L forms in milk samples after treatment was initiated. Cows harboring L forms typically yielded parental organisms after cessation of antibiotic therapy. No detectable changes occurred in antibiotic susceptibilities, coagulase production, or biochemical activities in strains induced to L form followed by reversion to the parental form. These results demonstrated that L forms can occur during treatment of bovine mastitis and that L forms may be one explanation for the poor response of staphylococcal bovine mastitis to antibiotic therapy.

Animals↗
PubMed2003

Methods for identification of Staphylococcus aureus isolates in cases of bovine mastitis.

A total of 272 staphylococcal isolates from cases of bovine mastitis (159 Staphylococcus aureus) belonging to 12 different species were identified with ID32 STAPH galleries, and 51 of them were confirmed by 16S rRNA gene (rrs) sequencing. The same isolates were examined for their hemolytic activity on sheep blood agar, DNase activity, and coagulase activity and with two rapid identification kits (Slidex Staph Plus kit and RAPIDEC Staph from Bio-Merieux). The results of this study confirm those obtained by other groups with hemolysis, DNase, and coagulase. Only 50% of S. aureus isolates from mastitis cases show coagulase activity after 4 h of incubation, and a 24-h incubation is necessary for the full sensitivity of this test. In contrast to results from other studies with human isolates, the Slidex Staph Plus kit was not sensitive enough for the identification of S. aureus from bovine mastitis samples. The aurease test of the RAPIDEC Staph kit showed 100% sensitivity and 100% specificity. Used in conjunction with hemolysis patterns, the RAPIDEC Staph kit is therefore very well adapted to rapid, efficient, and cost-effective identification of S. aureus in cultures from bovine mastitis samples. Sequencing of rrs genes also proved very efficient in identifying the Staphylococcus species encountered in these samples and confirming phenotypical identification results with unsatisfactory scores. With continuously improving technologies and decreasing costs, genetic identification methods like rrs gene sequencing will soon find a place in routine veterinary diagnostics.

Animals↗
PubMed1983

Mastitis in a large, zero-grazed dairy herd.

A zero-grazed herd of approximately 400 cows had a significant mastitis problem associated with Escherichia coli and Streptococcus uberis during a study over three and a half years. Dry cow therapy and post-milk teat dipping effectively controlled staphylococci and the bulk milk cell count averaged less than 400 X 10(3) cells/ml, but over 1800 clinical cases of mastitis occurred over this period, 32 per cent of which were associated with E coli and 25 per cent with Str uberis. Only 8 per cent of the cases associated with E coli showed obvious systemic disturbance and 75 per cent were cured following penicillin and streptomycin treatment. The incidence was highest during spring and summer when the housed cows were dirtiest. Gross teat-end contamination came mainly from sources other than cubicle bedding, and changing the bedding from sawdust to sand did not alter the incidence of clinical mastitis. It was not possible to maintain adequate cleanliness either inside or outside the parlour, nor maintain a trouble-free milking apparatus. The costs of mastitis in this herd during one year are calculated.

Animals↗
PubMed1984

Levamisole and bovine mastitis.

Levamisole is an anthelmintic drug which also has immunomodulatory properties. The application of these immunomodulatory properties in the prevention and, or, treatment of bovine mastitis is considered. In the light of the available evidence on the use of levamisole against mastitis and of our understanding of the pathogenesis of mastitis it is thought that the prospect of using levamisole beneficially is limited. However, drying-off and parturition are two times at which levamisole may have rational application in mastitis prevention.

Animals↗
PubMed1986

Prevalence, causes and laboratory diagnosis of subclinical mastitis in the goat.

Five goat herds were examined to determine the prevalence and causes of subclinical mastitis and to assess the value of some laboratory tests currently used on milk samples as aids in the diagnosis of caprine mastitis. In the 170 samples taken from the pairs of mammary glands of 85 goats, the prevalence of infection in the different herds ranged from 15 per cent to 79 per cent of halves. Just over one-third (36 per cent) of all halves were infected, the organisms isolated being coagulase-negative staphylococci (80 per cent), coagulase-positive staphylococci (16 per cent), alpha-haemolytic streptococci (2 per cent) and Pasteurella haemolytica (2 per cent). Neither anaerobic organisms nor mycoplasmas were found. Tests confirmed that the coagulase-positive staphylococci were pathogens but that the coagulase-negative staphylococci rarely caused detectable disease in the caprine udder. The large between-herd variation in the geometric mean cell counts of uninfected milk samples means that somatic cell counts, the Whiteside test and the California mastitis test, are unreliable as aids in the diagnosis of caprine mastitis.

Animals↗
PubMed1986

An assessment of the economic benefits of a mastitis control scheme.

Over a six-year period from 1979 to 1985 the incidence of mastitis among dairy herds being recorded in a veterinary practice in Gloucestershire decreased from 26.5 per cent to 19.6 per cent of cows affected each year and from 51.0 to 31.7 cases per 100 cows per year. Over the same period the rolling mean herd milk cell count fell from 346,000/ml to 243,000/ml and the usage of intramammary antibiotic tubes fell from 2.6 to 2.1 per lactating cow per year. The proportion of cases needing repeat treatments in a 12-month period also fell from 25 per cent to 10.6 per cent. Possible causes for the decrease in the incidence of mastitis are given. The cost of an average case of mastitis was estimated to be 40 pounds, and on this basis the farms involved reduced their losses from mastitis by 772 pounds per 100 cows per year, a more than 12-fold return on their investment in veterinary services.

Animals↗
PubMed1988

Progress in controlling mastitis in England and Wales.

Mastitis in England and Wales has been controlled over the past 20 years while the average size of dairy herds has doubled to 65 cows. The incidence of clinical mastitis has been reduced from approximately 120 to 150 cases per 100 cows to less than 50 cases. The limited data on the prevalence of subclinical mastitis indicate that it has been reduced from over 50 per cent of cows infected to less than half this level. The application of the major mastitis control measures on the farm has doubled over the period 1973 to 1983 and had reached 66 to 90 per cent for individual measures by 1983. The national mean cell count in milk has been reduced from 573,000 to 352,000 cells/ml between 1971 and 1986, and the proportion of herds having annual mean cell counts below 300,000 cells/ml has increased from 15.7 per cent to 40.7 per cent in the last eight years.

Animals↗
PubMed1989

Clinical trial of three therapeutic regimens for bovine mastitis.

An open, block randomised multi-centre clinical trial was performed in Norway during 1985 to 1987 to compare the therapeutic efficacy of three antibiotic regimens against clinical bovine mastitis caused by penicillin-sensitive bacteria. Two regimens consisted of procaine penicillin injected intramuscularly for either three or five days, and the third, the traditional Norwegian regimen, consisted of one intramuscular injection of a combination of procaine penicillin and dihydrostreptomycin followed by one intramammary treatment daily per infected quarter for four days. The study included 621 quarters with infectious mastitis from 439 cows. The most efficient regimen for all bacteria was five days systemic treatment (53.1 per cent cured), and the traditional regimen was second best (46.7 per cent cured). The least efficient regimen consisted of systemic therapy with procaine penicillin for three days (36.9 per cent cured). The difference between the therapeutic efficacies of the three regimens was reduced when the clinical mastitis was severe, and in severe mastitis caused by Staphylococcus aureus the difference was very small.

Animals↗
PubMed1989

Incidence of clinical mastitis on farms with low somatic cell counts in bulk milk.

A total of 1140 clinical cases of mastitis, with at least one inflamed quarter, were reported on 125 farms with somatic cell counts in bulk milk less than 150,000/ml. The average annual incidence was 17.9 cases per 100 cows and ranged from none to 80 cases per 100 cows. The microorganisms most frequently isolated were Escherichia coli (16.2 per cent), coagulase negative staphylococci (13.0 per cent), Staphylococcus aureus (9.6 per cent) and Streptococcus uberis (8.0 per cent). Only two cases of Streptococcus agalactiae were found. As the incidence of clinical mastitis increased, the proportion of S aureus also increased, while the proportions of E coli, S uberis and Streptococcus dysgalactiae remained about the same. Most of the clinical cases of mastitis occurred in early lactation, in November, December and January. However, after correction for the number of calvings per month, the incidence of mastitis was highest in the early summer months.

Animals↗
PubMed1991

Studies on the incidence of clinical mastitis and blood levels of vitamin E and selenium in dairy herds in England.

In a trial conducted in the south of England in January to February 1989, blood samples were obtained from nine dairy herds with more than 30 cases of clinical mastitis/100 cows and from nine herds with less than 30 cases/100 cows during the previous 12 months. Whole blood glutathione peroxidase (GSHPx) activity and plasma vitamin E concentration were determined for 12 cows in each herd. The mean (+/-sd) values for the herds with the lower incidence of mastitis were 7.57 +/- 1.86 micrograms/ml plasma vitamin E and 23.8 +/- 22.8 U/ml rbc GSHPx activity, compared with 7.74 +/- 1.69 micrograms/ml plasma vitamin E and 20.61 +/- 8.8 U/ml rbc GSHPx activity for the herds with the higher incidence of the disease. These values indicate that the vitamin E levels were generally adequate but that some animals and herds had low GSHPx activities, suggesting that their diets may have contained inadequate selenium. The activities of GSHPx and the vitamin E levels in plasma were not significantly different in the two groups of herds, and no relationship was found between the two nutrients and the incidence of clinical mastitis. However, there was a significant negative correlation between the activity of GSHPx and the bulk milk cell counts in the herds with a low incidence of mastitis suggesting that there was an association between the incidence of subclinical mastitis or inflammation and the selenium status of these herds.

Animals↗
PubMed1993

The economics of culling dairy cows with clinical mastitis.

Culling dairy cows with clinical mastitis reduces the incidence of the disease in dairy herds, but the costs of such action, in terms of reduced milk production and increased replacement costs, are generally thought to outweigh the benefits. To test this hypothesis a stochastic dynamic programming model was developed to establish the economically optimum time of replacement for dairy cows subject to variable levels of clinical mastitis infection, using average United Kingdom production and price parameters. The optimal stage at which to replace a dairy cow was found to be sensitive to changes in mastitis incidence and in critical price parameters within the bounds of commercial experience. This result indicates that an objective culling policy based on clinical mastitis records in addition to milk production potential may be economically viable.

Animals↗
PubMed2003

Risk factors for toxic mastitis in cows.

A case-control study of the management and disease risk factors associated with toxic mastitis in cows was carried out. Seventy-one cases satisfied all the selection criteria, and a subset of 41 cases in which pure growths of Escherichia coil were cultured from milk samples was also investigated. Conditional multiple logistic regression analysis of the 71 cases and matched controls revealed no statistically significant associations. However, among the subset of 41 cases and matched controls, the administration of calcium parenterally at calving (P < 0.01) and assistance at calving (P < 0.01) were both associated with toxic mastitis. Controlling for assistance at calving, the odds of a cow developing E coli toxic mastitis if it had received calcium parenterally at calving were 23 times higher than for a cow that had not received calcium. Similarly, controlling for the administration of calcium at calving, the odds of a cow developing E coli toxic mastitis if it had received assistance at calving were 11 times higher than for a cow that did not receive assistance.

Animal Husbandry↗
PubMed2006

Investigation of risk factors for clinical mastitis in British dairy herds with bulk milk somatic cell counts less than 150,000 cells/ml.

A sample of dairy farms in Great Britain with a monthly bulk milk somatic cell count of less than 150,000 cells/ml was enrolled into a 12-month prospective study. At the end of the study, a questionnaire on milking practice and other farm management practices was sent to the 482 farmers who had collected data on the occurrence of mastitis throughout the 12 months. The response rate was 93 per cent. The reported mean incidence of clinical mastitis was 36.9 cases per 100 cow-years. Factors associated with an increase in the incidence of clinical mastitis were cleaning out the straw yard less frequently than every six weeks, more than 5 per cent of cows leaking milk outside the parlour, checking the foremilk, wearing gloves during milking, an average annual milk yield of more than 7000 litres per cow, dipping or spraying teats before milking and keeping milk with a high somatic cell count out of the bulk tank. Factors associated with a decrease in the incidence of clinical mastitis were using a cloth to dry the teats after washing them as part of premilking preparation, using calving boxes for less than 40 per cent of calvings, and using both cubicles and straw yards to house dry cows, as opposed to other housing.

Animals↗
PubMed2006

Herd health planning: farmers' perceptions in relation to lameness and mastitis.

Between December 2002 and December 2003, the herd health planning activities on 61 dairy farms in the uk were compared with several measures of lameness and mastitis. Lameness had been reported as a problem in 53 of the herds directly by the farm and in the other eight by the nominating local veterinary practice; 54 of the farms also reported having a mastitis problem. Fifty-three (87 per cent) of the farms had some form of written herd health plan, of which 21 (40 per cent) had been in place for 12 months or less. All the farms were recording mastitis in some way, although 38 (62 per cent) of the farmers did not review these records and only four retained the results of a comprehensive record review. Farms defined as having a high incidence of mastitis were more likely to be reviewing their health records, but farms defined as having a high prevalence of lameness in a sentinel group of early lactation heifers were less likely to be reviewing their health records.

Animal Welfare↗
PubMedDate not supplied

Idiopathic granulomatous mastitis. Report of a case diagnosed with fine needle aspiration cytology.

BACKGROUND: Idiopathic granulomatous mastitis (IGM) is a benign, inflammatory breast disease of unknown etiology. Although it is rare, it frequently presents in a manner similar to that of breast carcinoma. CASE: A 41-year-old female developed unilateral idiopathic granulomatous mastitis, diagnosed by fine needle aspiration cytology. The clinical presentation and mammographic findings were suspicious for carcinoma. Fine needle aspiration cytology showed granulomatous inflammation. Histopathologic examination revealed a noncaseating, granulomatous lesion. Further clinical, radiologic and laboratory investigations disclosed no etiology. Therefore, we considered the case to be idiopathic granulomatous mastitis. CONCLUSION: Cytologically it may be difficult to distinguish IGM from carcinoma of the breast. Typical cytologic findings of the lesion are helpful to rule out cancer. In the differential diagnosis, all known causes of granulomatous changes have to be excluded before a diagnosis of idiopathic granulomatous mastitis is made.

Adult↗